Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Phakic IOLs offer good outcomes to high myopes and hyperopes
The U.S. FDA study of the Implantable Collamer Lens (ICL, STAAR Surgical)used to treat high myopia (mean preoperative refraction, -10 D) and availablein four lengths (11.5 to 13 mm) shows good visual results in 526 eyes. Thesedata were presented at the American Society of Cataract and Refractive Surgery(ASCRS) annual meeting.
Related Videos
Related Content
